The toxicity of soman in the African green monkey (Chlorocebus aethiops)

Toxicology Mechanisms and Methods

Volumn 17, Issue 5, 2007, Pages 255-264

  Despain, Kenneth E ^a   McDonough, John H ^a   McMonagle, Joseph D ^a   McGinley, Maura J ^a   Evans, Jackie ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acetylcholinesterase; African Green Monkey; Cardiac Troponin I; ECG; EEG; Intramuscular; LD50; Nonhuman Primate; Rhesus Macaque; Soman; Telemetry

Indexed keywords

ACETYLCHOLINESTERASE; SOMAN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CAUSE OF DEATH; CERCOPITHECIDAE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FASCICULATION; HEART; INTOXICATION; MALE; MASTICATION; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALIVATION; SEIZURE; TELEMETRY; TONIC CLONIC SEIZURE; TREMOR;

CERCOPITHECUS AETHIOPS; MACACA MULATTA; PAPIO; PRIMATES;

EID: 34250781543     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510600972733     Document Type: Article

References (56)

1. Adams, J. E. III, Bodor, G. S., Davila-Roman, V. G., Delmez, J. A., Apple, F. S., Fred, S., Ladenson, J. H., and Jaffe, A. S. 1993. Myocardial injury/infarction: cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 88(1):101-106.
2. Adams, N. L. 1990. The intramuscular lethality of soman (GD) in the cynomolgus monkey. USAMRICD-TR-90-06 US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, AD A224887.
3. Adams, N. L., von Bredow, J., and de Vera, H. V. 1976. Intramuscular lethality of GD (soman) in the rhesus monkey. Edgewood Arsenal Technical Report EB-TR-7603 Aberdeen Proving Ground, MD, AD A026821.
4. Anzueto, A., Berdine, G. G., Moore, G. T., Gleiser, C., Johnson, D., White, C. D., and Johanson, W. G. 1986. Pathophysiology of soman intoxication in primates. Toxicol. Appl. Pharmacol. 86:56-68.
5. Artenstein, A. W., Hicks, C. B., Goodwin, B. S., and Hilliard, J. K. 1991. Human infection with B virus following a needlestick injury. Rev. Infect. Dis. 13:288-291.
6. Baze, W. B. 1993. Soman-induced morphological changes: an overview in the nonhuman primate. J. Appl. Toxicol. 13:173-177.
7. Britt, J. O., Martin, J. L., Okerberg, C. V., and Dick, E. J. 2000. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp. Med. 50:133-139.
8. Busker, R. W., Zijlstra, J. J., Philippens, I. H., Groen, B., and Melchers, B. P. 1996. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys. Toxicology 112:183-194.
9. Carpentier, P., Foquin, A., Dorandeu, F., and Lallement, G. 2001. Delta activity as an early indicator for soman-induced brain damage: a review. Neurotoxicology 22(3):299-315.
10. Cummins, P., and Perry, S. V. 1978. Troponin I from human skeletal and cardiac muscles. Biochem. J. 171:251-259.
11. Davenport, D. S., Johnson, D. R., Holmes, G. P., Jewett, D. A., Ross, S. C., and Hilliard, J. K. 1994. Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan. Clin. Infect. Dis. 19:33-41.
12. DeCandole, C. A., Douglas, W. W., Evans, C. L., Spencer, K. E., Torrance, R. W., and Wilson, K. M. 1953. The failure of respiration in death by anticholinesterase poisoning. Br. J. Pharmacol. 8:466-475.
13. DeCandole, C. A., and McPhail, M. K. 1957. Sarin and paraoxon antagonism in different species. Can. J. Biochem. 35:1071-1083.
14. Dirnhuber, P., French, M. C., Green, D. M., Leadbeater, L., and Stratton, J. A. 1979. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:295-299.
15. Dixon, R. L. 1976. Problems in extrapolating toxicity data for laboratory animals to man. Environ. Health Perspect. 13:43-50.
16. Dixon, W. J., and Massey, F. J. 1981. Introduction to Statistical Analysis. New York: McGraw-Hill.
17. D'Mello, G. D., and Scott, E. A. M. 1986. Toxicity of sarin and GD in marmosets (Callithrix jacchus). Technical Paper 458 Chemical Defense Establishment, Porton Down, United Kingdom.
18. Fairbanks, L. 2002. Alternative old world primate models for non-AIDS research; African green monkeys (vervets). In Rhesus Monkey Demands in Biomedical Research; a Workshop Report. ed. National Academy of Sciences. Bethesda, MD: Research Resources Information Center.
19. Feaster, S. R., Gordon, R. K., Doctor, B. P., Clark, C. C., Maxwell, D. M., and Lenz, D. E. 2000. Unprocessed whole blood cholinesterase levels: WRAIR protocol development and validation. USAMRMC Bioscience Review. 3:1099-1107.
20. Fukuyama, G. S., and Askwich, W. E. 1963. Unpublished data cited in Adams et al. (1976) and Dirnhuber et al. (1979)
21. Holmes, G. P., Hilliard, J. K., Klontz, K. C., Rupert, A. H., Schindler, C. M., Parish, E., Griffin, D. G., Ward, G. S., Bernstein, N. D., and Bean, T. W. 1990. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann. Intern. Med. 112:833-839.
22. Johnson, R. P., Gold, A. J., and Freedman, G. 1958. Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following parathion and sarin intoxication. Amer. J. Physiol. 192:581-584.
23. Katrukha, A. 2003. Antibody selection strategies in cardiac troponin assays. In Cardiac Markers, Second edition. ed. A. H.B. Wu. New Jersey: Humana Press.
24. Koplovitz, I., Gresham, V. C., Dochterman, L. W., Kaminskis, A., and Stewart, J. R. 1992. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol. 66:622-628.
25. Krasovskii, G. N. 1976. Extrapolation of experimental data from animals to man. Environ. Health Perspect. 13:51-58.
26. Krummer, S., Thiermann, H., Worek, F., and Eyer, P. 2002. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate. Arch. Toxicol. 76(10):589-595.
27. Lallement, G., Demoncheaux, J. P., Foquin, A., Baubichon, D., Galonnier, M., Clarencon, D., and Dorandeu, F. 2002. Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug Chem. Toxicol. 25(3):309-320.
28. Lallement, G., Clarencon, D., Masqueliez, C., Baubichon, D., Galonnier, M., Burckhart, M., Peoc'h, M., andMestries, J. C. 1998. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch. Toxicol. 72:84-92.
29. Lallement, G., Clarencon, D., Galonnier, M., Baubichon, D., Burckhart, M. F., and Peoc'h, M. 1999. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch. Toxicol. 73:115-122.
30. Lallement, G., Mestries, J. C., Privat, A., Brochier, G., Baubichon, D., Carpentier, P., Kamenka, J. M., Sentenac-Roumanou, H., Burckhart, M. F., and Peoc'h, M. 1997. GK-11: promising additional neuroprotective therapy for organophosphate poisoning. NeuroToxicol. 18:851-856.
31. Lallement, G., Renault, F., Baubichon, D., Peoc'h, M., Burckhart, M. F., Galonnier, M., Clarencon, D., and Jourdil, N. 2000. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazepine pharmacokinetics. Arch. Toxicol. 74:480-486.
32. Lenz, D. E., Maxwell, D. M., Koplovitz, I., Clark, C. R., Capacio, B. R., Cerasoli, D. M., Federko, J. M., Luo, C., Saxena, A., Doctor, B. P., and Olson, C. 2005. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem. Biol. Interact. 15:157-158, 205-210.
33. Lipp, J. A. 1968. Cerebral electrical activity following soman administration. Arch. Int. Pharmacodyn. 175:161-169.
34. Lipp, J. A. 1972. Effect of diazepam upon soman-induced seizure activity and convulsions. EEG Clin. Neurophys. 32:557-560.
35. Lipp, J. A. 1973. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch. Int. Pharmacodyn. Ther. 202:244-251.
36. Lipp, J. A., and Dola, T. J. 1978. Effect of atropine upon the Cerebrovascular system during soman-induced respiratory depression. Arch. Int. Pharmacodyn. Ther. 235(2):211-218.
37. McDonough, J. H., Jaax, N. K., Crowley, R. A., Mays, M. Z., and Modrow, H. E. 1989. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:256-276.
38. Miller, C. O. 1967. Toxicology: use of nonhuman primates. Science 156:1772-1773.
39. Muggleton, N. G., Bowditch, A. P., Crofts, H. S., Scott, E. A., Pearce, P. C. 2003. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Psychopharmacology (Berl). 166(3):212-220.
40. Murphy, M. P., Blick, D. W., Dunn, M. A., Fanton, J. W., and Hartgraves, S. L. 1993. Diazepam as a treatment for nerve agent poisoning in primates. Aviat. Space Environ. Med. 64:110-1105.
41. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. Washington D. C.: National Academy Press.
42. Olson, C. T., Menton, R. G., Kiser, R., Matthews, M., Stotts, R., Romano, J. R., Koplovitz, I., Hackley, B. E. 1997. Efficacies of atropine/2-PAM and antropine/HI-6 in treating monkeys intoxicated with organophosphonate nerve agents. Int. J. Toxicol. 16:9-20.
43. Philippens, I. H., Vanwersch, R. A., Groen, B., Olivier, B., Bruijnzeel, P. L., and Melchers, B. P. 2000. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol. Sci. 53:84-91.
44. Schoen, F. J. 2005. The heart. In Robbins and Cotran Pathologic Basis of Disease, 7th edition. ed. V. Kumar, A. K. Abbas, and N. Fausto. Philadelphia: W. B. Saunders.
45. Shih, T. -M., Penetar, D. M., McDonough, J. H., Romano, J. A., and King, J. M. 1990. Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity. Brain Res. Bull. 24:429-436.
46. Sidell, F. R. 1997. Nerve agents. In Textbook of military medicine, Part I, Warfare, weaponry, and the casualty. ed. F. R. Sidell, E. T. Takafuji, and D. R. Franz. Washington D. C.: Office of the Surgeon general at TMM Publications, Walter Reed Army Medical Center,
47. TOSOH Medics. 2001. TOSOH AIA 600 Automated Immunoassay Analyzer. User Manual.
48. Tryphonas, L. and Clement J. G. 1996. Pathology of organophosphate poisoning revisited. Proceeding of the 1996 Med. Def. Bioscience Rev. 1: 447-456. Medical Defense Bioscience Review, United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. AD-A321840
49. van der Schans, M. J., Lander, B. J., van derWiel, H., Langenberg, J. P., and Benschop, H. P. 2003. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 15;191(1):48-62.
50. van Helden, H. P., Trap, H. C., Oostdijk, J. P., Kuijpers, W. C., Langenberg, J. P., and Benschop, H. P. 2003. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level. Toxicol. Appl. Pharmacol. 15;189(3):170-179.
51. van Helden, H. P., Trap, H. C., Kuijpers, W. C., Oostdijk, J. P., Benschop, H. P., and Langenberg, J. P. 2004 a. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. J. Appl. Toxicol. 24(1):59-68.
52. van Helden, H. P. M., van Der Wiel, H. J., De Lange, J., Busker, R. W., Melchers, B. P. C., and Wolthuis, O. L. 1992. Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl. Pharmacol. 115:50-56.
53. van Helden, H. P., Vanwersch, R. A., Kuijpers, W. C., Trap, H. C., Philippens, I. H., and Benschop, H. P. 2004b. Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. J. Appl. Toxicol. 24(6):475-483.
54. von Bredow, J., Corcoran, K., Maitland, G., Kaminskis, A., Adams, N., and Wade, J. 1991. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. Fund. Appl. Toxicol. 17:782-789.
55. Walker, D. B. 2006. Serum chemical biomarkers of cardiac injury for nonclinical safety testing. Toxicol. Pathol. 34:94-104.
56. Wetherell, J. R., and French, M. C. 1991. A comparison of decarbamyolation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species. Biochem. Pharmacol. 42:515-520.